Enoxacin
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282953This classification denotes an anti-infective agent with the molecular formula C15H17FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 325OGW249P, chemically known as 1,8-naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl but more generally known as enoxacin, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules Enoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06540MIG. The term ENOXACIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 40, No. 6, 1986, List 26). The World Health Organization schedules enoxacin in its Anatomical Therapeutic Chemical (ATC) Classification. ENOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: FC1C(N2CCNCC2)NC2N(CC)CC(C(=O)C2C1)C(=O)O.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.